T (CAR-T)

Torsten Schroeder1, Tjark Martens1, Lars Fransecky1

  • 1Department of Hematology and Oncology, Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein Kiel, Kiel University, Arnold-Heller-Str. 3, 24106, Kiel, Germany.

Intensive care medicine
|August 22, 2024
PubMed
概括

化学抗原受体T (CAR-T) 细胞疗法为血液恶性瘤提供了改善的预后,但可能导致严重的并发症. 本综述详细介绍了这些CAR-T细胞相关不良事件的诊断,管理和治疗.